Original Research
Accepted on 28 Jul 2025
Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study
in Cancer Immunity and Immunotherapy